The Diagnostic Odyssey: When the HD Test is Negative
At a Glance
If you have Huntington's symptoms but test negative, you may have a Huntington Disease-Like (HDL) syndrome. Doctors use a tiered testing approach, utilizing your geographic ancestry, broad genetic panels, and specific blood tests to pinpoint the exact cause of your symptoms.
Testing negative for the HTT gene expansion can feel like a relief, but it often brings a new set of questions. If you still have symptoms like involuntary movements (chorea), cognitive changes, or mood shifts, you are now entering what doctors call the diagnostic odyssey—the search for the true cause of your symptoms [1].
Approximately 1% to 12% of people who look like they have Huntington’s Disease (HD) actually have an HDL syndrome (Huntington Disease-Like) or another mimic [2][1]. Specialists now use a “tiered” approach to navigate this journey efficiently.
Important Warning on Genetic Counseling: Before embarking on this testing journey, it is critical that you receive formal genetic counseling, just as you likely did for the initial HD test. Finding out you have a C9orf72 expansion (which carries a high risk for ALS and Frontotemporal Dementia) or a PRNP mutation (which indicates a fatal prion disease) carries enormous emotional weight and severe prognosis implications. You and your family must be fully prepared for what these results might mean before the blood is drawn.
Tier 1: The “Big Three” Expansion Tests
The first step is usually to test for the most common mimics. These are often chosen based on your ancestry, as genetics are closely tied to geography [3].
- C9orf72: This is the most common cause of HD “mimics” in people of European descent [4].
- JPH3 (HDL2): This is the priority for patients with African ancestry, as it can look identical to classic HD [5][3].
- TBP (SCA17): This gene is often tested if you have significant balance issues (ataxia) or very prominent psychiatric symptoms [6].
Tier 2: Broad Genetic Panels
If the first tests are negative, doctors move to Next-Generation Sequencing (NGS) [7]. Instead of testing one gene at a time, these panels can scan dozens or even hundreds of genes simultaneously [8].
- Movement Disorder Panels: These scan for rare conditions like Chorea-Acanthocytosis or HDL1 [2].
- Whole Exome Sequencing (WES): In complex cases, doctors may look at every “protein-coding” part of your DNA to find ultra-rare mutations that standard tests might miss [9].
- The Waiting Period: Unlike simple blood tests, NGS and WES are highly complex. It can take weeks or even months for these results to return. This waiting period can be incredibly anxiety-inducing, making emotional support and symptom management essential during this time.
Essential “Bedside” Tests
While waiting for genetic results, simple blood tests and physical clues can provide vital shortcuts to a diagnosis:
- Serum Creatine Kinase (CK): A simple blood test for muscle enzymes. Persistently high levels are a major “red flag” for Neuroacanthocytosis syndromes [10].
- Peripheral Blood Smear: A technician looks at your blood under a microscope for acanthocytes—red blood cells that look “spiky” or like “thorny fruit” [11][12].
- Serum Ferritin: Low levels of this iron-storage protein, combined with certain brain MRI findings, can point to a rare condition called neuroferritinopathy [13].
How to Shorten Your Journey
To avoid a prolonged diagnostic odyssey, be your own advocate by providing these critical details to your neurology team:
- Ancestry Matters: Be as specific as possible about your family’s geographic origins [3].
- Watch for “Red Flags”: Tell your doctor immediately if you experience seizures, “drop attacks” (where your knees buckle), or if you find yourself involuntarily biting your tongue or lips [10].
- Review Your MRI: Ask your doctor if your brain scans show “brain iron” or “cerebellar atrophy” (shrinking of the balance center), as these point away from classic HD and toward specific mimics [14][2].
Note: Even with modern technology, a significant portion of these “mimic” cases may remain genetically unsolved, but testing for the major known causes is the best way to find answers and manage symptoms.
Common questions in this guide
What happens if I have Huntington's symptoms but my test is negative?
Why is genetic counseling necessary before testing for HD mimics?
What are the first genetic tests done after a negative HD test?
Can simple blood tests help diagnose Huntington disease-like syndromes?
Why does my doctor need to know my family's geographic ancestry?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since my HTT expansion test was negative, which specific 'Tier 1' genes, like C9orf72 or JPH3, should we test next based on my ancestry?
- 2.Could we check my serum Creatine Kinase (CK) and Ferritin levels to rule out neuroacanthocytosis or iron-related disorders?
- 3.Would a peripheral blood smear to look for acanthocytes be a helpful next step given my symptoms?
- 4.If the next round of single-gene tests is negative, is a broad 'Movement Disorder' or 'Chorea' NGS panel available to us?
- 5.What are the chances that my symptoms are caused by an 'intermediate allele' of the HTT gene versus a completely different syndrome?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Huntington's Disease, Huntington's Disease Look-Alikes, and Benign Hereditary Chorea: What's New?
Schneider SA, Bird T
Movement disorders clinical practice 2016; (3(4)):342-354 doi:10.1002/mdc3.12312.
PMID: 30713928 - 2
Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
Mariani LL, Tesson C, Charles P, et al.
JAMA neurology 2016; (73(9)):1105-14 doi:10.1001/jamaneurol.2016.2215.
PMID: 27400454 - 3
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era.
Ruscitti F, Origone P, Rosti G, et al.
Clinical case reports 2022; (10(10)):e6308 doi:10.1002/ccr3.6308.
PMID: 36237940 - 4
Screening for the C9ORF72 expansion in Greek Huntington Disease phenocopies and controls and meta-analysis of current data.
Rikos D, Marogianni C, Provatas A, et al.
Tremor and other hyperkinetic movements (New York, N.Y.) 2020; (10()):5 doi:10.5334/tohm.61.
PMID: 32775019 - 5
Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.
Krause A, Mitchell C, Essop F, et al.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2015; (168(7)):573-85 doi:10.1002/ajmg.b.32332.
PMID: 26079385 - 6
Spinocerebellar Ataxia Type 17 (SCA17).
Toyoshima Y, Takahashi H
Advances in experimental medicine and biology 2018; (1049()):219-231 doi:10.1007/978-3-319-71779-1_10.
PMID: 29427105 - 7
Genetic screening for Huntington disease phenocopies in Sweden: A tertiary center case series focused on short tandem repeat (STR) disorders.
Paucar M, Laffita-Mesa J, Niemelä V, et al.
Journal of the neurological sciences 2023; (451()):120707 doi:10.1016/j.jns.2023.120707.
PMID: 37379724 - 8
Diagnostic value of genetic testing in chorea: a retrospective monocentric study.
Fodor TA, Milenkovic I, Zimprich A, Brücke C
Journal of neurology 2026; (273(7)).
PMID: 42321428 - 9
Comparison of first-tier whole-exome sequencing with a multi-step traditional approach for diagnosing paediatric outpatients: An Italian prospective study.
Rosina E, Pezzani L, Apuril E, et al.
Molecular genetics & genomic medicine 2024; (12(1)):e2316 doi:10.1002/mgg3.2316.
PMID: 38041506 - 10
[Early Diagnosis of Chorea-Acanthocytosis: Orofacial Dyskinesia, Epileptic Seizures, and HyperCKemia].
Schneider C, Danek A, Hostmann A, et al.
Fortschritte der Neurologie-Psychiatrie 2017; (85(5)):270-273 doi:10.1055/s-0042-123042.
PMID: 28561176 - 11
Neuroacanthocytosis with unusual clinical features: A case report.
Zhu H, Feng XM, Zhao T, Liu JY
Medicine 2019; (98(2)):e14050 doi:10.1097/MD.0000000000014050.
PMID: 30633203 - 12
Huntington's disease-like disorders in Latin America and the Caribbean.
Walker RH, Gatto EM, Bustamante ML, et al.
Parkinsonism & related disorders 2018; (53()):10-20 doi:10.1016/j.parkreldis.2018.05.021.
PMID: 29853295 - 13
Neuroferritinopathy: Pathophysiology, Presentation, Differential Diagnoses and Management.
Kumar N, Rizek P, Jog M
Tremor and other hyperkinetic movements (New York, N.Y.) 2016; (6()):355 doi:10.7916/D8KK9BHF.
PMID: 27022507 - 14
Hereditary chorea - what else to consider when the Huntington's disease genetics test is negative?
Malek N, Newman EJ
Acta neurologica Scandinavica 2017; (135(1)):25-33 doi:10.1111/ane.12609.
PMID: 27150574
This page provides educational information about diagnostic testing for Huntington disease-like syndromes. It is not a substitute for professional medical advice, comprehensive genetic counseling, or formal diagnostic evaluation by a neurologist.
Get notified when new evidence is published on Huntington disease-like syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.